[What is established in the treatment of psoriasis?].
D000287:Administration, Topical; D000875:Anthralin / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005050:Etretinate / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D008628:Mercury / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy*; D013638:Tars / Q000627:therapeutic use; D014467:Ultraviolet Therapy
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D013638:Tars; D005050:Etretinate; D008628:Mercury; D000875:Anthralin; D008727:Methotrexate
Was ist gesichert in der Behandlung der Psoriasis?